Mary Ayres

2.2k total citations
55 papers, 1.7k citations indexed

About

Mary Ayres is a scholar working on Molecular Biology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mary Ayres has authored 55 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 17 papers in Genetics and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mary Ayres's work include Chronic Lymphocytic Leukemia Research (17 papers), Biochemical and Molecular Research (14 papers) and Acute Lymphoblastic Leukemia research (12 papers). Mary Ayres is often cited by papers focused on Chronic Lymphocytic Leukemia Research (17 papers), Biochemical and Molecular Research (14 papers) and Acute Lymphoblastic Leukemia research (12 papers). Mary Ayres collaborates with scholars based in United States, Brazil and United Kingdom. Mary Ayres's co-authors include Varsha Gandhi, Michael J. Keating, William G. Wierda, Robert G. Kilbourn, Ghislaine A. Joly, Kumudha Balakrishnan, Christine M. Stellrecht, Carlos O. Rodriguez, William Plunkett and Billie Nowak and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Mary Ayres

53 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Ayres United States 27 865 482 354 352 319 55 1.7k
Shingo Yano Japan 23 478 0.6× 349 0.7× 956 2.7× 309 0.9× 506 1.6× 173 1.9k
Edvardas Kaminskas United States 20 1.2k 1.4× 285 0.6× 513 1.4× 140 0.4× 405 1.3× 33 2.1k
Carlos J. Carrera United States 22 1.0k 1.2× 866 1.8× 203 0.6× 397 1.1× 621 1.9× 35 2.2k
Sinisa Dovat United States 28 1.0k 1.2× 243 0.5× 705 2.0× 697 2.0× 280 0.9× 105 2.1k
Annemieke Kuil Netherlands 19 617 0.7× 565 1.2× 216 0.6× 154 0.4× 1.4k 4.3× 23 2.4k
Sophie Raynaud France 25 1.2k 1.4× 802 1.7× 1.4k 3.9× 444 1.3× 458 1.4× 86 2.8k
Rebecca B. Klisovic United States 29 1.6k 1.8× 398 0.8× 1.4k 3.8× 308 0.9× 400 1.3× 96 2.6k
Franklin C. Harwood United States 16 919 1.1× 213 0.4× 180 0.5× 88 0.3× 547 1.7× 17 1.4k
R. Osieka Germany 28 1.1k 1.3× 233 0.5× 376 1.1× 63 0.2× 693 2.2× 89 2.4k
Srikumar Sahasranaman United States 18 379 0.4× 202 0.4× 116 0.3× 136 0.4× 359 1.1× 42 1.2k

Countries citing papers authored by Mary Ayres

Since Specialization
Citations

This map shows the geographic impact of Mary Ayres's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Ayres with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Ayres more than expected).

Fields of papers citing papers by Mary Ayres

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Ayres. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Ayres. The network helps show where Mary Ayres may publish in the future.

Co-authorship network of co-authors of Mary Ayres

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Ayres. A scholar is included among the top collaborators of Mary Ayres based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Ayres. Mary Ayres is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ayres, Mary, Natalia Baran, Gamze Bildik, et al.. (2023). Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemia. Frontiers in Oncology. 13. 1161254–1161254. 16 indexed citations
2.
Aslan, Burcu, Görkem Kısmalı, Ganiraju C. Manyam, et al.. (2022). Pirtobrutinib inhibits wild-type and mutant Bruton’s tyrosine kinase-mediated signaling in chronic lymphocytic leukemia. Blood Cancer Journal. 12(5). 33 indexed citations
3.
Sarkar, Aloke, Görkem Kısmalı, Burcu Aslan, et al.. (2020). AMG-176, an Mcl-1 Antagonist, Shows Preclinical Efficacy in Chronic Lymphocytic Leukemia. Clinical Cancer Research. 26(14). 3856–3867. 43 indexed citations
4.
Sarkar, Aloke, Christine M. Stellrecht, Hima V. Vangapandu, et al.. (2020). Ataxia-telangiectasia mutated interacts with Parkin and induces mitophagy independent of kinase activity. Evidence from mantle cell lymphoma. Haematologica. 106(2). 495–512. 25 indexed citations
5.
Vangapandu, Hima V., Ondřej Havránek, Mary Ayres, et al.. (2017). B-cell Receptor Signaling Regulates Metabolism in Chronic Lymphocytic Leukemia. Molecular Cancer Research. 15(12). 1692–1703. 40 indexed citations
6.
Patel, Viralkumar, Betty Lamothe, Mary Ayres, et al.. (2017). Pharmacodynamics and proteomic analysis of acalabrutinib therapy: similarity of on-target effects to ibrutinib and rationale for combination therapy. Leukemia. 32(4). 920–930. 27 indexed citations
7.
Vangapandu, Hima V., Mary Ayres, Christopher A. Bristow, et al.. (2017). The Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation in Chronic Lymphocytic Leukemia Cells. Neoplasia. 19(10). 762–771. 33 indexed citations
8.
Patel, Viralkumar, Kumudha Balakrishnan, Елена Бибикова, et al.. (2016). Comparison of Acalabrutinib, A Selective Bruton Tyrosine Kinase Inhibitor, with Ibrutinib in Chronic Lymphocytic Leukemia Cells. Clinical Cancer Research. 23(14). 3734–3743. 109 indexed citations
9.
Bartholomeusz, Geoffrey, et al.. (2016). Synthesis and cytotoxic activity of novel A-ring cleaved ursolic acid derivatives in human non-small cell lung cancer cells. European Journal of Medicinal Chemistry. 123. 317–331. 42 indexed citations
10.
Zhang, Honghao, Raghu Gogada, Neelu Yadav, et al.. (2011). Defective Molecular Timer in the Absence of Nucleotides Leads to Inefficient Caspase Activation. PLoS ONE. 6(1). e16379–e16379. 11 indexed citations
11.
Dennison, Jennifer B., Mary Ayres, Kumar Kaluarachchi, William Plunkett, & Varsha Gandhi. (2010). Intracellular Succinylation of 8-Chloroadenosine and Its Effect on Fumarate Levels. Journal of Biological Chemistry. 285(11). 8022–8030. 12 indexed citations
12.
Stellrecht, Christine M., et al.. (2009). A unique RNA-directed nucleoside analog is cytotoxic to breast cancer cells and depletes cyclin E levels. Breast Cancer Research and Treatment. 121(2). 355–364. 21 indexed citations
13.
Chen, Lisa S., Billie Nowak, Mary Ayres, et al.. (2009). Inhibition of ATP synthase by chlorinated adenosine analogue. Biochemical Pharmacology. 78(6). 583–591. 27 indexed citations
14.
Chandra, Dhyan, Shawn B. Bratton, Maria D. Person, et al.. (2006). Intracellular Nucleotides Act as Critical Prosurvival Factors by Binding to Cytochrome C and Inhibiting Apoptosome. Cell. 125(7). 1333–1346. 98 indexed citations
15.
Cooper, Todd M., Mary Ayres, Billie Nowak, & Varsha Gandhi. (2004). Biochemical modulation of cytarabine triphosphate by clofarabine. Cancer Chemotherapy and Pharmacology. 55(4). 361–368. 62 indexed citations
16.
Ayres, Mary, Chadi Nabhan, Chunguang Ma, et al.. (2004). In vitro assessment of nucleoside analogs in multiple myeloma. Cancer Chemotherapy and Pharmacology. 54(2). 113–21. 10 indexed citations
17.
Gandhi, Varsha, Wei Chen, Mary Ayres, et al.. (2002). Plasma and cellular pharmacology of 8-chloro-adenosine in mice and rats. Cancer Chemotherapy and Pharmacology. 50(2). 85–94. 31 indexed citations
18.
Gandhi, Varsha, William Plunkett, Carlos O. Rodriguez, et al.. (1998). Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response.. Journal of Clinical Oncology. 16(11). 3607–3615. 79 indexed citations
19.
Joly, Ghislaine A., et al.. (1994). Effects of NG-Methyl-L-arginine, NG-Nitro-L-arginine, and Aminoguanidine on Constitutive and Inducible Nitric Oxide Synthase in Rat Aorta. Biochemical and Biophysical Research Communications. 199(1). 147–154. 129 indexed citations
20.
Ayres, Mary, et al.. (1991). Rapid preparation of lysate for immunoprecipitation using a low protein-binding micro-filter.. PubMed. 10(5). 578–80. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shingo Yano Breakdown of academic impact, for papers by Edvardas Kaminskas Breakdown of academic impact, for papers by Carlos J. Carrera Breakdown of academic impact, for papers by Sinisa Dovat Breakdown of academic impact, for papers by Annemieke Kuil Breakdown of academic impact, for papers by Sophie Raynaud Breakdown of academic impact, for papers by Rebecca B. Klisovic Breakdown of academic impact, for papers by Franklin C. Harwood Breakdown of academic impact, for papers by R. Osieka Breakdown of academic impact, for papers by Srikumar Sahasranaman
Rankless by CCL
2026